Table 1.
Gene | Location and accession number | Ion selectivity or signaling | Agonist (EC50) | Antagonist (IC50) | Modulator | References for pharmacological reagents |
---|---|---|---|---|---|---|
ASIC1 | Human: 12q13.12NM_001095.4 (ASIC1a) HM991481 (ASIC1b) | Na+/Ca2+ | MitTx: ASIC1a (9.4 nM) ASIC1b (23 nM) | PcTx1 (1 nM) Mambalgin ASIC1a (55 nM) Hi1aDiminazene AmilorideA-317567 | Big dynorphin & dynaorphin A (EC50 ∼30 µM) Spermine | 120–124 125,126 |
Mouse: chr 15NM_009597.2 (ASIC1a) NM_001289791 (ASIC1b) | ||||||
Identity: ASIC1a 97.9% ASIC1b 93.8% | ||||||
ASIC2 | Human: 17q11.2-q12NM_001094 (ASIC2a) NM_183377.2 (ASIC2b) | Na+ | Diminazene Amiloride | Zn2+ | 125 , 127 | |
Mouse: chr 11NM_001034013 (ASIC2a) NM_007384 (ASIC2b) | ||||||
Identity: ASIC2a 99.2% ASIC2b 97.2% | ||||||
ASIC3 | Human: 7q36.1NM_004769.4 | Na+ | MitTx (830 nM) | APETx2 (63 nM) AmilorideA-317567 | GMQ (67 µM) Neuropeptide SF (50 µM) lactate | 126,128–130 |
Mouse: chr 5 NM_183000.2 | ||||||
Identity: 83.3% | ||||||
PAC/ASOR | Human: 1q32.3NM_001198862.2 | Cl− | pregnenolone sulfate | 11 | ||
Mouse: chr 1 NM_025864.4 | ||||||
Identity: 90.3% | ||||||
GPR4 | Human: 19q13.32NM_005282 | GsG12/13Gqpossibly Gi | Compound 3b (67 nM) NE 52-QQ 57 (70 nM hGPR4; 1.8 µM rGPR4) | 84 , 131 | ||
Mouse: Chr 7NM_175668 | ||||||
Identity: 91.5% | ||||||
GPR65 (TDAG8) | Human: 14q31.3NM_003608 | Gs | ZINC13684400 (positive) ZINC62678696 (negative) | 106 | ||
Mouse: chr 12 NM_008152.3 | ||||||
Identity: 78.5% | ||||||
GPR68 (OGR1) | Human: 14q32.11NM_003485 | Gq, Gspossibly Giand G12/13 | CARTPT (76–96) 3.2 µMOsteocrin (115–133) 0.4 µMCorticotropin (17–40) 1.8 µM | Cu2+ (µM range) Zn2+ (µM range) | Ogerin (positive modulator for Gs pathway) Lorazepam (non-specific) MS48107 | 72 , 106 , 132 |
Mouse: Chr 12NM_175493 | ||||||
Identity: 92.1% |
CARTPT: cocaine- and amphetamine-regulated protein; GMQ: 2-guanidine-4-methylquinazoline; PcTx1: psalmotoxin 1.